Conjugates of-electron-pair-donating heteroaromatic nitrogen-comprising compounds
AssigneeAscendis Pharma A/S
InventorsNicola BISEK, Samuel WEISBROD
Life of this patent
Estimating the term…
Abstract
The present invention relates to conjugates of π-electron-pair-donating heteroaromatic nitrogen-comprising drugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising said conjugates and the use of said conjugates as medicaments.
Claims25
A conjugate or a pharmaceutically acceptable salt thereof comprising at least one moiety -D conjugated via at least one moiety -L1-L2- to at least one moiety Z, wherein a moiety -L1- is conjugated to a π-electron-pair-donating heteroaromatic N of a moiety -D and wherein the linkage between -D and -L1- is reversible and wherein a moiety -L2- is conjugated to Z, wherein
- each -D is independently a π-electron-pair-donating heteroaromatic N-comprising moiety of a drug D-H;
- each -L2- is independently a single bond or a spacer moiety;
- each Z is independently a polymeric moiety or a C8-24 alkyl;
- each -L1- is independently a linker moiety of formula (I):
- wherein
- the dashed line indicates the attachment to the π-electron-pair-donating heteroaromatic N of -D;
- n is an integer selected from the group consisting of 0, 1, 2, 3 and 4;
- ═X1 is selected from the group consisting of ═O, ═S and ═N(R4);
- —X2— is selected from the group consisting of —O—, —S—, —N(R5)— and —C(R6)(R6a)—;
- —X3— is selected from the group consisting of
- C(R10)(R10a)—, —C(R11)(R11a)—C(R12)(R12a)—, —O— and —C(O)—;
- —R1, —R1a, —R6, —R6a, —R10, —R10a, —R11, —R11a, —R12, —R12a and each of —R2 and —R2a are independently selected from the group consisting of —H, —C(O)OH, halogen, —CN, —OH, C1-6 alkyl, C2-6 alkenyl and C2-6 alkynyl;
- wherein C1-6 alkyl, C2-6 alkenyl and C2-6 alkynyl are optionally substituted with one or more —R13, which are the same or different;
- and wherein C1-6 alkyl, C2-6 alkenyl and C2-6 alkynyl are optionally interrupted by one or more groups selected from the group consisting of -T-, —C(O)O—, —O—, —C(O)—, —C(O)N(R14)—, —S(O)2N(R14)—, —S(O)N(R14)—, —S(O)2—, —S(O)—, —N(R14)S(O)2N(R14a)—, —S—, —N(R14), —OC(OR14)(R14a)—, —N(R14)C(O)N(R14a)— and —OC(O)N(R14)—;
- —R3, —R4, —R5, —R7, —R8 and —R9 are independently selected from the group consisting of —H, -T, —CN, C1-6 alkyl, C2-6 alkenyl and C2-6 alkynyl;
- wherein C1-6 alkyl, C2-6 alkenyl and C2-6 alkynyl are optionally substituted with one or more —R13, which are the same or different;
- and wherein C1-6 alkyl, C2-6 alkenyl and C2-6 alkynyl are optionally interrupted by one or more groups selected from the group consisting of -T-, —C(O)O—, —O—, —C(O)—, —C(O)N(R14)—, —S(O)2N(R14)—, —S(O)N(R14)—, —S(O)2—, —S(O)—, —N(R14)S(O)2N(R14a)—, —S—, —N(R14)—, —OC(OR14)(R14a)—, —N(R14)C(O)N(R14a)— and —OC(O)N(R14)—;
- each T is independently selected from the group consisting of phenyl, naphthyl, indenyl, indanyl, tetralinyl, C3-10 cycloalkyl, 3- to 10-membered heterocyclyl and 8- to 11-membered heterobicyclyl;
- wherein each T is independently optionally substituted with one or more —R13, which are the same or different;
- wherein —R13 is selected from the group consisting of —H, —NO2, —OCH3, —CN, —N(R14)(R14a), —OH, —C(O)OH and C1-6 alkyl;
- wherein C1-6 alkyl is optionally substituted with one or more halogen, which are the same or different;
- wherein —R14 and —R14a are independently selected from the group consisting of —H and C1-6 alkyl;
- wherein C1-6 alkyl is optionally substituted with one or more halogen, which are the same or different;
- optionally, one or more of the pairs —R1/—R1a, —R2/—R2a, two adjacent —R2, —R6/—R6a, —R10/—R10a, —R11/—R11a, —R12/—R12a and —R3/—R9 are joined together with the atom to which they are attached to form a C3-10 cycloalkyl, 3- to 10-membered heterocyclyl or an 8- to 11-membered heterobicyclyl;
- optionally, one or more of the pairs —R1/—R2, —R1/—R5, —R1/—R6, —R1/—R9, —R1/—R10, —R2/—R5, —R3/—R6a, —R4/—R5, —R4/—R6, —R5/—R10, —R6/—R10 and —R11/—R12 are joined together with the atoms to which they are attached to form a ring -A-;
- wherein -A- is selected from the group consisting of phenyl, naphthyl, indenyl, indanyl, tetralinyl, C3-10 cycloalkyl, 3- to 10-membered heterocyclyl and 8- to 11-membered heterobicyclyl;
- optionally, —R1 and an adjacent —R2 form a carbon-carbon double bond provided that n is selected from the group consisting of 1, 2, 3 and 4;
- optionally, two adjacent —R2 form a carbon-carbon double bond provided that n is selected from the group consisting of 2, 3 and 4;
- provided that if —X2— is —N(R5)—, —X3— is selected from the group consisting of
- and the distance between the nitrogen atom marked with an asterisk and the carbon atom marked with an asterisk in formula (I) is 5, 6 or 7 atoms and if present the carbon-carbon double bond formed between —R1 and —R2 or two adjacent —R2 is in a cis configuration;
- and
- each -L1- is substituted with -L2- and optionally further substituted.
Dependencies are inferred from the claim text.